welcome
Reuters

Reuters

Health

Health

Exclusive-Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say

Reuters
Summary
Nutrition label

81% Informative

Merck KGaA is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics .

If the talks are successful, a deal could be signed in the coming weeks .

Merck has suffered high-profile setbacks recently in late-stage drug trials.

VR Score

92

Informative language

98

Neutral language

62

Article tone

formal

Language

English

Language complexity

53

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links